News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,786 Results
Type
Article (40496)
Company Profile (289)
Press Release (650001)
Section
Business (205091)
Career Advice (2047)
Deals (35534)
Drug Delivery (86)
Drug Development (80966)
Employer Resources (170)
FDA (16144)
Job Trends (14948)
News (346338)
Policy (32648)
Tag
Academia (2611)
Alliances (49497)
Alzheimer's disease (1235)
Approvals (16074)
Artificial intelligence (132)
Bankruptcy (355)
Best Places to Work (11591)
Biotechnology (205)
Breast cancer (120)
Cancer (1084)
Cardiovascular disease (97)
Career advice (1712)
Cell therapy (233)
Clinical research (64311)
Collaboration (388)
Compensation (197)
COVID-19 (2563)
C-suite (96)
Data (1120)
Diabetes (152)
Diagnostics (6251)
Earnings (84989)
Employer resources (148)
Events (110026)
Executive appointments (312)
FDA (16679)
Funding (351)
Gene therapy (178)
GLP-1 (582)
Government (4354)
Healthcare (18770)
Infectious disease (2648)
Inflammatory bowel disease (106)
Interviews (314)
IPO (16338)
Job creations (3710)
Job search strategy (1466)
Layoffs (418)
Legal (7899)
Lung cancer (170)
Manufacturing (178)
Medical device (13248)
Medtech (13253)
Mergers & acquisitions (19270)
Metabolic disorders (402)
Neuroscience (1512)
NextGen Class of 2024 (6564)
Non-profit (4512)
Northern California (1477)
Obesity (232)
Opinion (184)
Patents (102)
People (56657)
Phase I (19977)
Phase II (28336)
Phase III (21115)
Pipeline (456)
Postmarket research (2559)
Preclinical (8535)
Radiopharmaceuticals (238)
Rare diseases (218)
Real estate (6033)
Regulatory (21658)
Research institute (2383)
Resumes & cover letters (353)
Southern California (1304)
Startups (3617)
United States (13509)
Vaccines (549)
Weight loss (167)
Date
Today (130)
Last 7 days (804)
Last 30 days (3803)
Last 365 days (35776)
2024 (32812)
2023 (40250)
2022 (51416)
2021 (55936)
2020 (54414)
2019 (46902)
2018 (35248)
2017 (32447)
2016 (31873)
2015 (37854)
2014 (31618)
2013 (26710)
2012 (28894)
2011 (29577)
2010 (27546)
Location
Africa (735)
Arizona (194)
Asia (37548)
Australia (6110)
California (3329)
Canada (1290)
China (247)
Colorado (145)
Connecticut (152)
Europe (80351)
Florida (459)
Georgia (122)
Illinois (342)
Indiana (198)
Kansas (96)
Maryland (578)
Massachusetts (2609)
Michigan (157)
Minnesota (274)
New Jersey (958)
New York (962)
North Carolina (706)
Northern California (1477)
Ohio (142)
Pennsylvania (844)
South America (1115)
Southern California (1304)
Texas (463)
Utah (90)
Washington State (363)
690,786 Results for "geovax labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
GeoVax Announces Multiple Patent Issuances and Allowances
GeoVax Labs, Inc. announced multiple actions by global patent offices strengthening the Company’s intellectual property assets.
February 13, 2024
·
5 min read
Press Releases
Registration is Now Open for Tribe Public’s Webinar Event “Now Is Not the Time to Monkey(pox) Around” Featuring GeoVax Lab’s CEO
August 22, 2024
·
3 min read
BioMidwest
Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023
GeoVax Labs, Inc. announced the presentation of preclinical vaccine efficacy data for GEO-CM02, a multi-antigen investigational SARS-CoV-2 vaccine.
November 14, 2023
·
7 min read
BioMidwest
GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities
GeoVax Labs, Inc., a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced an update on key strategic initiatives.
October 24, 2023
·
6 min read
BioMidwest
GeoVax to Participate in Upcoming November 2023 Investor and Industry Events
GeoVax Labs, Inc. announced that members of its senior management team and other scientific representatives will participate in four upcoming investor and industry events during November.
October 25, 2023
·
3 min read
Drug Development
GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the closure of patient enrollment for the Phase 1/2 clinical study evaluating Gedeptin® in patients suffering from advanced head and neck cancer.
January 4, 2024
·
7 min read
GeoVax Labs to Participate in A.G.P.’s Virtual Healthcare Conference
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that it will participate in the Alliance Global Partners’ Virtual Healthcare Conference being held May 23-24, 2023.
May 9, 2023
·
1 min read
Press Releases
GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board
August 8, 2024
·
6 min read
Press Releases
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
November 11, 2024
·
1 min read
Drug Development
GeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients
GeoVax Labs, Inc. (Nasdaq: GOVX) announced today the presentation of updates on the development of its next-generation SARS-CoV-2 vaccine, GEO-CM04S1, including preliminary data from an ongoing Phase 2 clinical trial, during the Vaccines Summit Boston 2023 and the Congress for the International Society for the Advancement of Cytometry (CYTO) 2023 meetings.
May 24, 2023
·
6 min read
1 of 69,079
Next
